| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Diseases, Inborn | 15 | 2025 | 459 | 3.260 |
Why?
|
| Exome | 37 | 2024 | 1064 | 2.510 |
Why?
|
| Sequence Analysis, DNA | 19 | 2019 | 1707 | 2.130 |
Why?
|
| Genetic Testing | 17 | 2025 | 1056 | 1.880 |
Why?
|
| Prenatal Diagnosis | 10 | 2025 | 631 | 1.510 |
Why?
|
| Intellectual Disability | 15 | 2021 | 1048 | 1.200 |
Why?
|
| High-Throughput Nucleotide Sequencing | 14 | 2025 | 899 | 1.190 |
Why?
|
| Mutation | 23 | 2021 | 5941 | 0.830 |
Why?
|
| Phenotype | 28 | 2021 | 4304 | 0.750 |
Why?
|
| Genome, Human | 7 | 2019 | 1279 | 0.710 |
Why?
|
| Chromosome Disorders | 4 | 2021 | 315 | 0.660 |
Why?
|
| Fabry Disease | 6 | 2018 | 18 | 0.650 |
Why?
|
| DNA Copy Number Variations | 9 | 2020 | 1004 | 0.630 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2013 | 999 | 0.630 |
Why?
|
| Alleles | 13 | 2019 | 1609 | 0.610 |
Why?
|
| Muscle Hypotonia | 6 | 2019 | 188 | 0.600 |
Why?
|
| Abnormalities, Multiple | 8 | 2021 | 964 | 0.600 |
Why?
|
| Rare Diseases | 4 | 2023 | 201 | 0.580 |
Why?
|
| Sequence Analysis, RNA | 4 | 2025 | 416 | 0.580 |
Why?
|
| Genetic Counseling | 6 | 2017 | 233 | 0.550 |
Why?
|
| Genetic Variation | 10 | 2019 | 1508 | 0.550 |
Why?
|
| Nucleic Acid Hybridization | 4 | 2009 | 297 | 0.540 |
Why?
|
| Genomics | 9 | 2022 | 1546 | 0.530 |
Why?
|
| Mutation, Missense | 9 | 2021 | 891 | 0.510 |
Why?
|
| Humans | 113 | 2025 | 126754 | 0.490 |
Why?
|
| Child, Preschool | 41 | 2024 | 14347 | 0.460 |
Why?
|
| Chromosome Aberrations | 6 | 2019 | 570 | 0.460 |
Why?
|
| Genome-Wide Association Study | 3 | 2019 | 1728 | 0.440 |
Why?
|
| Exons | 10 | 2020 | 757 | 0.440 |
Why?
|
| Female | 73 | 2025 | 68330 | 0.440 |
Why?
|
| Pedigree | 17 | 2021 | 1656 | 0.430 |
Why?
|
| DNA-Binding Proteins | 9 | 2022 | 1877 | 0.420 |
Why?
|
| Child | 47 | 2024 | 25101 | 0.420 |
Why?
|
| Developmental Disabilities | 6 | 2019 | 718 | 0.410 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2014 | 167 | 0.410 |
Why?
|
| Microarray Analysis | 3 | 2019 | 224 | 0.400 |
Why?
|
| Gene Rearrangement | 3 | 2011 | 321 | 0.400 |
Why?
|
| Seizures | 5 | 2021 | 847 | 0.390 |
Why?
|
| DNA Mutational Analysis | 7 | 2018 | 781 | 0.390 |
Why?
|
| Fetal Diseases | 3 | 2016 | 454 | 0.390 |
Why?
|
| Male | 66 | 2024 | 62543 | 0.380 |
Why?
|
| Genes, Recessive | 4 | 2021 | 184 | 0.370 |
Why?
|
| Dystrophin | 2 | 2009 | 41 | 0.360 |
Why?
|
| Haploinsufficiency | 7 | 2021 | 265 | 0.360 |
Why?
|
| Sequence Deletion | 4 | 2016 | 510 | 0.360 |
Why?
|
| INDEL Mutation | 3 | 2020 | 91 | 0.340 |
Why?
|
| Physical and Rehabilitation Medicine | 2 | 2022 | 32 | 0.340 |
Why?
|
| Germ-Line Mutation | 3 | 2024 | 352 | 0.330 |
Why?
|
| Epilepsy | 4 | 2021 | 844 | 0.330 |
Why?
|
| Adult | 34 | 2025 | 30410 | 0.330 |
Why?
|
| Enzyme Replacement Therapy | 3 | 2018 | 15 | 0.320 |
Why?
|
| Micrognathism | 3 | 2021 | 65 | 0.320 |
Why?
|
| Autistic Disorder | 3 | 2021 | 363 | 0.320 |
Why?
|
| Incidental Findings | 3 | 2015 | 121 | 0.310 |
Why?
|
| Heterozygote | 11 | 2021 | 690 | 0.310 |
Why?
|
| Adolescent | 30 | 2024 | 20002 | 0.300 |
Why?
|
| Hand Deformities, Congenital | 2 | 2021 | 95 | 0.290 |
Why?
|
| Gene Dosage | 6 | 2017 | 436 | 0.290 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2021 | 205 | 0.290 |
Why?
|
| Infant | 24 | 2024 | 12771 | 0.290 |
Why?
|
| Mosaicism | 2 | 2020 | 230 | 0.280 |
Why?
|
| Congenital Abnormalities | 2 | 2025 | 300 | 0.280 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2018 | 526 | 0.280 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2008 | 65 | 0.270 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2019 | 2746 | 0.270 |
Why?
|
| Genotyping Techniques | 3 | 2018 | 108 | 0.270 |
Why?
|
| alpha-Galactosidase | 6 | 2018 | 20 | 0.270 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2024 | 3262 | 0.260 |
Why?
|
| Membrane Proteins | 5 | 2018 | 1569 | 0.260 |
Why?
|
| Homozygote | 6 | 2019 | 540 | 0.260 |
Why?
|
| Chromosome Deletion | 3 | 2017 | 642 | 0.250 |
Why?
|
| Megalencephaly | 2 | 2017 | 59 | 0.250 |
Why?
|
| Cell Cycle Proteins | 3 | 2019 | 677 | 0.250 |
Why?
|
| Mucopolysaccharidosis II | 4 | 2011 | 18 | 0.240 |
Why?
|
| Craniofacial Abnormalities | 2 | 2019 | 252 | 0.240 |
Why?
|
| Fibroblasts | 4 | 2024 | 819 | 0.240 |
Why?
|
| Urogenital Abnormalities | 2 | 2019 | 160 | 0.240 |
Why?
|
| Kidney Diseases | 5 | 2019 | 481 | 0.220 |
Why?
|
| Patient Satisfaction | 2 | 2020 | 456 | 0.220 |
Why?
|
| Stillbirth | 1 | 2025 | 97 | 0.220 |
Why?
|
| Language Development Disorders | 2 | 2017 | 177 | 0.210 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2017 | 350 | 0.210 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2019 | 992 | 0.210 |
Why?
|
| Loss of Function Mutation | 3 | 2021 | 151 | 0.210 |
Why?
|
| Cell Transdifferentiation | 1 | 2024 | 58 | 0.200 |
Why?
|
| Heart Defects, Congenital | 5 | 2018 | 1853 | 0.200 |
Why?
|
| Young Adult | 14 | 2021 | 9665 | 0.200 |
Why?
|
| Genetic Association Studies | 5 | 2019 | 808 | 0.200 |
Why?
|
| Fetus | 2 | 2018 | 578 | 0.200 |
Why?
|
| Pregnancy | 8 | 2025 | 7373 | 0.200 |
Why?
|
| Syndrome | 8 | 2018 | 1137 | 0.200 |
Why?
|
| Computational Biology | 3 | 2017 | 834 | 0.190 |
Why?
|
| Microcephaly | 3 | 2016 | 343 | 0.190 |
Why?
|
| Facies | 3 | 2017 | 156 | 0.190 |
Why?
|
| Point Mutation | 3 | 2016 | 334 | 0.190 |
Why?
|
| Comparative Genomic Hybridization | 4 | 2013 | 560 | 0.180 |
Why?
|
| De Lange Syndrome | 2 | 2019 | 43 | 0.180 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2022 | 63 | 0.180 |
Why?
|
| Gene Duplication | 3 | 2008 | 363 | 0.180 |
Why?
|
| Nervous System Diseases | 3 | 2024 | 393 | 0.180 |
Why?
|
| Musculoskeletal Abnormalities | 2 | 2019 | 63 | 0.180 |
Why?
|
| Uniparental Disomy | 1 | 2021 | 40 | 0.180 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2021 | 12 | 0.170 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2021 | 13 | 0.170 |
Why?
|
| Prolotherapy | 1 | 2021 | 1 | 0.170 |
Why?
|
| Calcineurin | 1 | 2021 | 59 | 0.170 |
Why?
|
| Rotator Cuff Injuries | 1 | 2021 | 9 | 0.170 |
Why?
|
| Job Syndrome | 1 | 2021 | 18 | 0.170 |
Why?
|
| Shoulder Pain | 1 | 2021 | 18 | 0.170 |
Why?
|
| Genetic Carrier Screening | 2 | 2020 | 68 | 0.170 |
Why?
|
| Infant, Newborn | 11 | 2018 | 8347 | 0.170 |
Why?
|
| Platelet-Rich Plasma | 1 | 2021 | 19 | 0.170 |
Why?
|
| Transcription Factors | 4 | 2019 | 2337 | 0.170 |
Why?
|
| Spectrin | 1 | 2021 | 70 | 0.160 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 114 | 0.160 |
Why?
|
| Potassium Channels | 1 | 2021 | 152 | 0.160 |
Why?
|
| RNA Splicing | 4 | 2025 | 230 | 0.160 |
Why?
|
| Metalloendopeptidases | 2 | 2017 | 99 | 0.160 |
Why?
|
| Fragile X Syndrome | 1 | 2020 | 117 | 0.150 |
Why?
|
| Base Sequence | 5 | 2022 | 2757 | 0.150 |
Why?
|
| Actins | 2 | 2021 | 311 | 0.150 |
Why?
|
| Autopsy | 2 | 2016 | 112 | 0.150 |
Why?
|
| Osteoarthritis | 1 | 2021 | 97 | 0.150 |
Why?
|
| Thanatophoric Dysplasia | 1 | 2019 | 5 | 0.150 |
Why?
|
| Dynamins | 1 | 2019 | 44 | 0.150 |
Why?
|
| Lymphangioma, Cystic | 1 | 2019 | 16 | 0.150 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2019 | 18 | 0.150 |
Why?
|
| Iduronate Sulfatase | 2 | 2011 | 20 | 0.150 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2019 | 16 | 0.150 |
Why?
|
| Adenosine Triphosphatases | 2 | 2017 | 186 | 0.150 |
Why?
|
| Achondroplasia | 1 | 2019 | 24 | 0.150 |
Why?
|
| Acrocephalosyndactylia | 1 | 2019 | 21 | 0.150 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 58 | 0.150 |
Why?
|
| Collagen Type I | 1 | 2019 | 113 | 0.140 |
Why?
|
| Biological Variation, Population | 1 | 2018 | 26 | 0.140 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2018 | 13 | 0.140 |
Why?
|
| Carrier Proteins | 3 | 2021 | 1011 | 0.140 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2019 | 50 | 0.140 |
Why?
|
| Osteochondrodysplasias | 1 | 2019 | 66 | 0.140 |
Why?
|
| Genetics, Medical | 2 | 2016 | 116 | 0.140 |
Why?
|
| Hydrops Fetalis | 1 | 2019 | 84 | 0.140 |
Why?
|
| Proline-Rich Protein Domains | 1 | 2018 | 2 | 0.140 |
Why?
|
| Endocytosis | 1 | 2018 | 120 | 0.140 |
Why?
|
| Iris Diseases | 1 | 2018 | 10 | 0.140 |
Why?
|
| Dwarfism | 2 | 2016 | 102 | 0.140 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2019 | 220 | 0.140 |
Why?
|
| Ultrasonography | 2 | 2022 | 933 | 0.140 |
Why?
|
| Mitochondrial Proteins | 2 | 2017 | 272 | 0.140 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2019 | 107 | 0.140 |
Why?
|
| Confidentiality | 2 | 2016 | 103 | 0.140 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2018 | 111 | 0.140 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein U | 1 | 2017 | 8 | 0.140 |
Why?
|
| Mitochondrial Diseases | 1 | 2019 | 145 | 0.140 |
Why?
|
| Insurance, Health | 1 | 2018 | 134 | 0.140 |
Why?
|
| Chorionic Villi Sampling | 2 | 2015 | 44 | 0.140 |
Why?
|
| Chromosome Banding | 2 | 2008 | 136 | 0.130 |
Why?
|
| Insurance Coverage | 1 | 2018 | 116 | 0.130 |
Why?
|
| Eye Abnormalities | 1 | 2018 | 98 | 0.130 |
Why?
|
| Amino Acid Sequence | 6 | 2016 | 2541 | 0.130 |
Why?
|
| Students, Medical | 1 | 2022 | 337 | 0.130 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2017 | 20 | 0.130 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2017 | 42 | 0.130 |
Why?
|
| Pyrroline Carboxylate Reductases | 1 | 2016 | 6 | 0.130 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2016 | 17 | 0.130 |
Why?
|
| Glycoproteins | 2 | 2011 | 333 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 283 | 0.130 |
Why?
|
| Bone Diseases, Developmental | 1 | 2017 | 60 | 0.130 |
Why?
|
| Software | 2 | 2019 | 711 | 0.130 |
Why?
|
| Situs Inversus | 1 | 2016 | 25 | 0.130 |
Why?
|
| Genes, Dominant | 2 | 2015 | 241 | 0.130 |
Why?
|
| NF-kappa B | 1 | 2019 | 438 | 0.130 |
Why?
|
| p21-Activated Kinases | 1 | 2017 | 54 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2017 | 109 | 0.130 |
Why?
|
| Bone and Bones | 1 | 2019 | 294 | 0.130 |
Why?
|
| Tumor Protein p73 | 1 | 2016 | 27 | 0.130 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2019 | 167 | 0.130 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2017 | 47 | 0.130 |
Why?
|
| Sudden Infant Death | 1 | 2016 | 32 | 0.130 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2016 | 37 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2019 | 283 | 0.130 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 102 | 0.120 |
Why?
|
| Radiculopathy | 1 | 2016 | 6 | 0.120 |
Why?
|
| Curriculum | 1 | 2022 | 765 | 0.120 |
Why?
|
| Psychomotor Disorders | 1 | 2016 | 29 | 0.120 |
Why?
|
| Neurons | 2 | 2024 | 1919 | 0.120 |
Why?
|
| Founder Effect | 1 | 2016 | 34 | 0.120 |
Why?
|
| Cystic Fibrosis | 2 | 2012 | 263 | 0.120 |
Why?
|
| Feeding and Eating Disorders | 1 | 2017 | 73 | 0.120 |
Why?
|
| Limb Deformities, Congenital | 1 | 2017 | 109 | 0.120 |
Why?
|
| Death, Sudden | 1 | 2016 | 44 | 0.120 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 48 | 0.120 |
Why?
|
| Molecular Sequence Data | 6 | 2016 | 3584 | 0.120 |
Why?
|
| Retrospective Studies | 11 | 2025 | 17005 | 0.120 |
Why?
|
| DNA Helicases | 2 | 2017 | 229 | 0.120 |
Why?
|
| Physicians | 2 | 2020 | 620 | 0.120 |
Why?
|
| Ethics, Medical | 2 | 2016 | 399 | 0.120 |
Why?
|
| Geminin | 1 | 2015 | 7 | 0.120 |
Why?
|
| Polyhydramnios | 1 | 2016 | 54 | 0.120 |
Why?
|
| Failure to Thrive | 1 | 2016 | 88 | 0.120 |
Why?
|
| Transposases | 1 | 2016 | 40 | 0.120 |
Why?
|
| Functional Laterality | 1 | 2016 | 172 | 0.120 |
Why?
|
| Neoplasms | 2 | 2024 | 2855 | 0.120 |
Why?
|
| DNA Damage | 1 | 2019 | 498 | 0.120 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2016 | 81 | 0.120 |
Why?
|
| Patella | 1 | 2015 | 27 | 0.120 |
Why?
|
| Rhabdomyolysis | 1 | 2016 | 35 | 0.120 |
Why?
|
| Leukoencephalopathies | 1 | 2016 | 60 | 0.120 |
Why?
|
| Genetic Linkage | 1 | 2017 | 463 | 0.120 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2016 | 58 | 0.120 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2016 | 113 | 0.120 |
Why?
|
| Congenital Microtia | 1 | 2015 | 26 | 0.110 |
Why?
|
| Muscle Weakness | 1 | 2016 | 86 | 0.110 |
Why?
|
| Vesicular Transport Proteins | 1 | 2016 | 137 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 361 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 374 | 0.110 |
Why?
|
| Mitochondria | 2 | 2019 | 730 | 0.110 |
Why?
|
| Karyotyping | 2 | 2012 | 312 | 0.110 |
Why?
|
| Cardiomyopathies | 2 | 2016 | 500 | 0.110 |
Why?
|
| Disease | 1 | 2016 | 123 | 0.110 |
Why?
|
| Growth Disorders | 1 | 2015 | 183 | 0.110 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2012 | 46 | 0.110 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2016 | 234 | 0.110 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2016 | 209 | 0.110 |
Why?
|
| Amniotic Fluid | 1 | 2015 | 147 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2014 | 108 | 0.110 |
Why?
|
| Telemedicine | 1 | 2020 | 488 | 0.100 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 472 | 0.100 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2016 | 476 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 478 | 0.100 |
Why?
|
| CHARGE Syndrome | 1 | 2013 | 8 | 0.100 |
Why?
|
| Genes, X-Linked | 1 | 2013 | 60 | 0.100 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 321 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 2225 | 0.100 |
Why?
|
| Gaucher Disease | 1 | 2013 | 12 | 0.100 |
Why?
|
| Glucosylceramidase | 1 | 2013 | 26 | 0.100 |
Why?
|
| Muscle Spasticity | 1 | 2013 | 55 | 0.100 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2012 | 19 | 0.100 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2014 | 88 | 0.100 |
Why?
|
| Autophagy | 1 | 2016 | 404 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1135 | 0.100 |
Why?
|
| Inheritance Patterns | 3 | 2018 | 129 | 0.100 |
Why?
|
| Introns | 2 | 2016 | 281 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 576 | 0.100 |
Why?
|
| Informed Consent | 1 | 2015 | 337 | 0.100 |
Why?
|
| Genes, Duplicate | 1 | 2012 | 16 | 0.090 |
Why?
|
| Munc18 Proteins | 1 | 2012 | 20 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2016 | 437 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 1098 | 0.090 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2012 | 64 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2022 | 1195 | 0.090 |
Why?
|
| DNA Replication | 1 | 2013 | 347 | 0.090 |
Why?
|
| Autism Spectrum Disorder | 1 | 2017 | 423 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2025 | 2883 | 0.090 |
Why?
|
| Gene Deletion | 4 | 2017 | 767 | 0.090 |
Why?
|
| Alu Elements | 1 | 2011 | 67 | 0.090 |
Why?
|
| Referral and Consultation | 1 | 2014 | 557 | 0.080 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2013 | 250 | 0.080 |
Why?
|
| Heart Diseases | 2 | 2006 | 490 | 0.080 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 1861 | 0.080 |
Why?
|
| Animals | 10 | 2021 | 33051 | 0.080 |
Why?
|
| Recombination, Genetic | 1 | 2011 | 418 | 0.080 |
Why?
|
| Organ Specificity | 2 | 2007 | 396 | 0.080 |
Why?
|
| Methods | 1 | 2008 | 121 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 2065 | 0.070 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2008 | 37 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2008 | 138 | 0.070 |
Why?
|
| Noonan Syndrome | 1 | 2008 | 31 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2008 | 93 | 0.070 |
Why?
|
| Muscles | 2 | 2019 | 222 | 0.070 |
Why?
|
| Zebrafish | 2 | 2021 | 402 | 0.070 |
Why?
|
| Genetic Heterogeneity | 2 | 2018 | 129 | 0.070 |
Why?
|
| United States | 6 | 2022 | 11310 | 0.070 |
Why?
|
| Nuclear Proteins | 3 | 2018 | 1204 | 0.070 |
Why?
|
| Kidney | 3 | 2019 | 1283 | 0.060 |
Why?
|
| Databases, Genetic | 2 | 2019 | 481 | 0.060 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 2 | 2017 | 79 | 0.060 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2006 | 12 | 0.060 |
Why?
|
| Hearing Loss | 1 | 2008 | 199 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2006 | 89 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 2 | 2008 | 337 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2006 | 213 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2016 | 622 | 0.060 |
Why?
|
| Amino Acid Substitution | 2 | 2016 | 398 | 0.060 |
Why?
|
| Registries | 2 | 2008 | 1536 | 0.060 |
Why?
|
| Middle Aged | 9 | 2020 | 27697 | 0.060 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2004 | 66 | 0.050 |
Why?
|
| Gene Expression | 2 | 2021 | 1482 | 0.050 |
Why?
|
| Genotype | 3 | 2019 | 2595 | 0.050 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2006 | 271 | 0.050 |
Why?
|
| Caenorhabditis elegans | 2 | 2016 | 228 | 0.050 |
Why?
|
| Cell Cycle | 2 | 2017 | 585 | 0.050 |
Why?
|
| Disease Management | 2 | 2018 | 541 | 0.050 |
Why?
|
| Germ Cells | 1 | 2024 | 197 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2004 | 348 | 0.050 |
Why?
|
| Texas | 2 | 2024 | 3551 | 0.050 |
Why?
|
| Electroencephalography | 2 | 2021 | 821 | 0.050 |
Why?
|
| Lung Diseases | 1 | 2006 | 395 | 0.050 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2022 | 39 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2017 | 767 | 0.050 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2022 | 52 | 0.050 |
Why?
|
| DNA Mismatch Repair | 1 | 2022 | 45 | 0.050 |
Why?
|
| Laboratories | 1 | 2023 | 78 | 0.050 |
Why?
|
| Homologous Recombination | 1 | 2022 | 99 | 0.050 |
Why?
|
| Face | 2 | 2017 | 193 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2017 | 1398 | 0.050 |
Why?
|
| Musculoskeletal System | 1 | 2022 | 18 | 0.050 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2022 | 77 | 0.040 |
Why?
|
| Decision Making | 1 | 2006 | 664 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2017 | 1536 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2023 | 6214 | 0.040 |
Why?
|
| Problem Behavior | 1 | 2021 | 39 | 0.040 |
Why?
|
| Choice Behavior | 1 | 2022 | 132 | 0.040 |
Why?
|
| Mice | 4 | 2019 | 17596 | 0.040 |
Why?
|
| Career Choice | 1 | 2022 | 158 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2019 | 3709 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 3695 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2021 | 12546 | 0.040 |
Why?
|
| Aged | 5 | 2020 | 20344 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2006 | 1259 | 0.040 |
Why?
|
| Nephrons | 1 | 2019 | 16 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2019 | 88 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2019 | 7 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2019 | 20 | 0.040 |
Why?
|
| Xenopus laevis | 1 | 2019 | 118 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2021 | 269 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 74 | 0.040 |
Why?
|
| Peroxisomes | 1 | 2019 | 41 | 0.040 |
Why?
|
| Transferrin | 1 | 2018 | 45 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 300 | 0.040 |
Why?
|
| Urinary Tract | 1 | 2019 | 61 | 0.040 |
Why?
|
| Endosomes | 1 | 2018 | 62 | 0.040 |
Why?
|
| Outpatients | 1 | 2020 | 254 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2019 | 160 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 2018 | 53 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2018 | 4954 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2018 | 132 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 157 | 0.040 |
Why?
|
| Myelin Sheath | 1 | 2018 | 119 | 0.030 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2021 | 248 | 0.030 |
Why?
|
| Infant Care | 1 | 2017 | 46 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 4429 | 0.030 |
Why?
|
| Mass Screening | 1 | 2003 | 802 | 0.030 |
Why?
|
| Transcriptome | 1 | 2024 | 1052 | 0.030 |
Why?
|
| Survival of Motor Neuron 2 Protein | 1 | 2017 | 13 | 0.030 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2017 | 33 | 0.030 |
Why?
|
| Philadelphia Chromosome | 1 | 2017 | 42 | 0.030 |
Why?
|
| Growth Charts | 1 | 2016 | 14 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2021 | 4472 | 0.030 |
Why?
|
| Oryzias | 1 | 2016 | 9 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 27 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 28 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 109 | 0.030 |
Why?
|
| Codon | 1 | 2016 | 95 | 0.030 |
Why?
|
| Consent Forms | 1 | 2016 | 22 | 0.030 |
Why?
|
| Coroners and Medical Examiners | 1 | 2016 | 15 | 0.030 |
Why?
|
| Models, Animal | 1 | 2018 | 452 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 302 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2018 | 737 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2013 | 1293 | 0.030 |
Why?
|
| Age of Onset | 2 | 2008 | 609 | 0.030 |
Why?
|
| Everolimus | 1 | 2016 | 48 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 76 | 0.030 |
Why?
|
| Injections, Epidural | 1 | 2016 | 4 | 0.030 |
Why?
|
| Diseases in Twins | 1 | 2017 | 89 | 0.030 |
Why?
|
| Betamethasone | 1 | 2016 | 8 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2017 | 151 | 0.030 |
Why?
|
| Diagnosis | 1 | 2016 | 31 | 0.030 |
Why?
|
| Triamcinolone | 1 | 2016 | 13 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 2017 | 124 | 0.030 |
Why?
|
| Fathers | 1 | 2017 | 70 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 191 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 187 | 0.030 |
Why?
|
| Heterotaxy Syndrome | 1 | 2016 | 53 | 0.030 |
Why?
|
| Optic Atrophy | 1 | 2016 | 46 | 0.030 |
Why?
|
| Skin | 1 | 2019 | 516 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2003 | 932 | 0.030 |
Why?
|
| Family Health | 1 | 2017 | 248 | 0.030 |
Why?
|
| Arabs | 1 | 2016 | 29 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 622 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 348 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 234 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2017 | 356 | 0.030 |
Why?
|
| Cysteine | 1 | 2016 | 137 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2016 | 90 | 0.030 |
Why?
|
| Amino Acids | 1 | 2018 | 615 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2015 | 63 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2003 | 923 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 162 | 0.030 |
Why?
|
| Cell Death | 1 | 2016 | 236 | 0.030 |
Why?
|
| Disclosure | 1 | 2016 | 147 | 0.030 |
Why?
|
| Family | 1 | 2018 | 575 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 122 | 0.030 |
Why?
|
| Interview, Psychological | 1 | 2015 | 103 | 0.030 |
Why?
|
| Physical Examination | 1 | 2016 | 160 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2018 | 392 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 579 | 0.030 |
Why?
|
| Cytokines | 1 | 2021 | 1320 | 0.030 |
Why?
|
| Sirolimus | 1 | 2016 | 222 | 0.030 |
Why?
|
| Proteolysis | 1 | 2015 | 177 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2016 | 189 | 0.030 |
Why?
|
| Brain | 2 | 2016 | 3038 | 0.030 |
Why?
|
| Patients | 1 | 2015 | 122 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2015 | 585 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 415 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 360 | 0.030 |
Why?
|
| Drosophila | 1 | 2018 | 767 | 0.030 |
Why?
|
| National Human Genome Research Institute (U.S.) | 1 | 2013 | 19 | 0.030 |
Why?
|
| Bile Acids and Salts | 1 | 2016 | 243 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2015 | 229 | 0.030 |
Why?
|
| Mothers | 1 | 2017 | 363 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 578 | 0.030 |
Why?
|
| Axons | 1 | 2016 | 373 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 1661 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 2893 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 1224 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 1057 | 0.020 |
Why?
|
| Metabolomics | 1 | 2016 | 455 | 0.020 |
Why?
|
| Parents | 1 | 2020 | 1072 | 0.020 |
Why?
|
| Karyotype | 1 | 2012 | 29 | 0.020 |
Why?
|
| Drug Substitution | 1 | 2013 | 24 | 0.020 |
Why?
|
| Platelet Count | 1 | 2013 | 130 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2013 | 240 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 121 | 0.020 |
Why?
|
| Maternal Age | 1 | 2012 | 129 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 136 | 0.020 |
Why?
|
| Critical Care | 1 | 2017 | 668 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 2560 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2016 | 761 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2014 | 1054 | 0.020 |
Why?
|
| Brain Waves | 1 | 2012 | 43 | 0.020 |
Why?
|
| Patient Preference | 1 | 2013 | 140 | 0.020 |
Why?
|
| Length of Stay | 1 | 2017 | 1377 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 3907 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2012 | 784 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2013 | 311 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 730 | 0.020 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2011 | 81 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 2011 | 29 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 946 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2012 | 800 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 808 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 1014 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2012 | 200 | 0.020 |
Why?
|
| Spleen | 1 | 2011 | 253 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 429 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5114 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2011 | 342 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2397 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 536 | 0.020 |
Why?
|
| Sweating | 1 | 2008 | 7 | 0.020 |
Why?
|
| Amniocentesis | 1 | 2009 | 73 | 0.020 |
Why?
|
| Body Temperature Regulation | 1 | 2008 | 50 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2008 | 156 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2008 | 22 | 0.020 |
Why?
|
| NADPH Oxidases | 1 | 2008 | 108 | 0.020 |
Why?
|
| Quality of Life | 2 | 2008 | 2029 | 0.020 |
Why?
|
| Neuralgia | 1 | 2008 | 47 | 0.020 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2008 | 108 | 0.020 |
Why?
|
| Awards and Prizes | 1 | 2008 | 64 | 0.020 |
Why?
|
| Body Height | 1 | 2008 | 191 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2009 | 296 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 2007 | 113 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1758 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 1222 | 0.020 |
Why?
|
| Drug Tolerance | 1 | 2006 | 38 | 0.020 |
Why?
|
| Vital Capacity | 1 | 2006 | 78 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2008 | 369 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2006 | 150 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2007 | 311 | 0.010 |
Why?
|
| Safety | 1 | 2006 | 210 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 2004 | 51 | 0.010 |
Why?
|
| Body Weight | 1 | 2008 | 970 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2007 | 539 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 1194 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 1428 | 0.010 |
Why?
|
| Liver | 1 | 2011 | 1765 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2006 | 1584 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 785 | 0.010 |
Why?
|
| DNA | 1 | 2005 | 1419 | 0.010 |
Why?
|
| Incidence | 1 | 2003 | 3251 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 2036 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 6668 | 0.010 |
Why?
|